103 filings
6-K
BYSI
BeyondSpring Inc
18 Dec 20
BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors
6:01am
SC 13D/A
Decheng Capital China Life Sciences USD Fund III, L.P.
8 Dec 20
BeyondSpring / Decheng Capital China Life Sciences USD Fund III ownership change
4:20pm
6-K
BYSI
BeyondSpring Inc
23 Nov 20
Current report (foreign)
4:16pm
424B5
BYSI
BeyondSpring Inc
19 Nov 20
Prospectus supplement for primary offering
4:12pm
424B5
BYSI
BeyondSpring Inc
17 Nov 20
Prospectus supplement for primary offering
4:19pm
6-K
1rg 5vq7oxl
17 Nov 20
BeyondSpring Announces Third Quarter 2020 Financial Results and Provides Business Updates
8:06am
6-K
4c4u4wubo5v
16 Nov 20
Current report (foreign)
7:22am
6-K
1qchmg0eg14163
13 Nov 20
BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly
7:28am
EFFECT
qsh1qn8mv 6nsqjik2q
13 Nov 20
Notice of effectiveness
12:15am
CORRESP
d42y pi03
10 Nov 20
Correspondence with SEC
12:00am
UPLOAD
snk4e5
9 Nov 20
Letter from SEC
12:00am
F-3
vbk60b4
3 Nov 20
Shelf registration (foreign)
8:24am
6-K
tkju1
22 Sep 20
BeyondSpring Appoints Elizabeth Czerepak as Chief Financial Officer
5:22pm
6-K
jyw0r7er
3 Sep 20
BeyondSpring Provides Second-Quarter 2020 Financial Results and Business Updates
8:00am
6-K
g7721 6lvn2g0uv
19 Aug 20
BeyondSpring Appoints Forty Seven, Inc., Co-Founder and Stanford Hematology Veteran, Dr. Ravindra Majeti, to Board of Directors
6:43am
SC 13D
7sui01gjg
27 Jul 20
BeyondSpring / Decheng Capital China Life Sciences USD Fund III ownership change
5:19pm
S-8
souqwg 0qm
24 Jul 20
Registration of securities for employees
4:05pm
6-K
d51fc7ys2ztf7npx
24 Jul 20
Current report (foreign)
4:03pm
6-K
w56rwn3
23 Jun 20
Current report (foreign)
4:09pm
424B5
0j76337vb fin
19 Jun 20
Prospectus supplement for primary offering
4:31pm